BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8300889)

  • 21. [Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].
    Thyss A; Falewee MN; Leborgne L; Viens P; Schneider M; Demard F
    Bull Cancer; 1987; 74(4):381-5. PubMed ID: 3663962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion.
    Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S; Bayrak I
    J Clin Pharm Ther; 2004 Jun; 29(3):267-71. PubMed ID: 15153089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil.
    Lestuzzi C; Viel E; Picano E; Meneguzzo N
    Am J Med; 2001 Sep; 111(4):316-8. PubMed ID: 11566462
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
    Scott PA; Ferchow L; Hobson A; Curzen NP
    Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of coronary spasm induced by 5-fluorouracil.
    Gorgulu S; Celik S; Tezel T
    Acta Cardiol; 2002 Oct; 57(5):381-3. PubMed ID: 12405579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac arrest--a manifestation of 5-fluorouracil cardiotoxicity.
    Millward MJ; Ganju V; Buck M
    Aust N Z J Med; 1988 Aug; 18(5):693-5. PubMed ID: 3245824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible.
    Güvenç TS; Celiker E; Ozcan KS; Ilhan E; Eren M
    Chin Med J (Engl); 2012 Sep; 125(18):3349-51. PubMed ID: 22964337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study.
    Akhtar SS; Salim KP; Bano ZA
    Oncology; 1993; 50(6):441-4. PubMed ID: 8233284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prinzmetal's angina during 5-fluorouracil chemotherapy.
    Kleiman NS; Lehane DE; Geyer CE; Pratt CM; Young JB
    Am J Med; 1987 Mar; 82(3):566-8. PubMed ID: 3826112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm.
    Myerburg RJ; Kessler KM; Mallon SM; Cox MM; deMarchena E; Interian A; Castellanos A
    N Engl J Med; 1992 May; 326(22):1451-5. PubMed ID: 1574091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac side effects of 5-fluorouracil].
    May D; Wandl U; Becher R; Niederle N; Schmidt CG
    Dtsch Med Wochenschr; 1990 Apr; 115(16):618-21. PubMed ID: 2328669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac toxicity of fluoro-uracil. Typical and atypical aspects. Apropos of 8 cases].
    Ferrari E; Taillan B; Tibi T; Darmon JP; Gibelin P; Chichmanian RM; Dujardin P; Morand P
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):191-5. PubMed ID: 1642435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorouracil cardiotoxicity.
    Anand AJ
    Ann Pharmacother; 1994 Mar; 28(3):374-8. PubMed ID: 8193429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac toxicity of 5-fluorouracil. Reflections on a case].
    Perreau P; Jaulmes H; Bokowy C; Demaldent JE
    Ann Otolaryngol Chir Cervicofac; 1990; 107(8):577-80. PubMed ID: 2085263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiotoxicity resembling myocardial infarction that occurs during chemotherapy with 5-fluorouracil.
    Gul M; Duzenli A; Bircan M; Cander B; Kocak S; Ozdemir K
    Saudi Med J; 2005 Nov; 26(11):1821-2. PubMed ID: 16311676
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
    Porta C; Moroni M; Ferrari S; Nastasi G
    Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.